- Delivering Pan India
Tazira Lyo® (Piperacillin + Tazobactam) Piperacillin 4 g + Tazobactam 500 mg (4.5 g) injection by Abbott. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Piperacillin 4 g + Tazobactam 500 mg (4.5 g) |
|---|---|
| Manufacturer | Abbott |
| Country | India |
| Pack size | Piperacillin 4 g + Tazobactam 500 mg (4.5 g): 1 vial / carton |
| Storage | Store as per carton and leaflet; original sealed pack |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Tazira Lyo® (Piperacillin + Tazobactam) Piperacillin 4 g + Tazobactam 500 mg (4.5 g) Injection — Piperacillin and Tazobactam for Injection: A Sourcing Guide for Hospitals and Pharmacies
Tazira® Lyo is a brand of piperacillin 4 g and tazobactam 500 mg for injection (4.5 g), marketed by Abbott. According to the US prescribing information for piperacillin and tazobactam (Zosyn®), the combination is indicated for intra-abdominal infections, nosocomial pneumonia, skin and skin structure infections, female pelvic infections and community-acquired pneumonia. Use of Tazira Lyo in India is defined by its approved pack insert and the Indian regulator. The decision to prescribe piperacillin + tazobactam, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Tazira Lyo® (piperacillin + tazobactam) Piperacillin 4 g + Tazobactam 500 mg (4.5 g) injection to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the anti-biotic medicines category. Supply is in bulk/wholesale quantities only.
Tazira Lyo contains piperacillin 4 g with tazobactam 500 mg as a lyophilised powder in a single-use vial for intravenous use, administered under medical supervision.
How it works, according to the label: The reference label describes piperacillin as a penicillin-class antibacterial and tazobactam as a β-lactamase inhibitor that extends its activity against β-lactamase-producing bacteria.
The current US prescribing information for ZOSYN® (piperacillin and tazobactam) for injection, the reference brand of the same combination (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Tazira Lyo pack insert.
The reference label summarises its clinical studies by indication. In bloodstream infection with ceftriaxone-resistant Escherichia coli or Klebsiella pneumoniae, the MERINO randomized trial compared piperacillin-tazobactam with meropenem and was published by Harris et al. in JAMA in 2018. Evidence is cited for information only and is not a recommendation for any patient; the approved prescribing information governs.
| Strength | Dosage form | Pack size (as shown on the carton) |
|---|---|---|
| Piperacillin 4 g + Tazobactam 500 mg (4.5 g) | Lyophilised powder for injection or infusion | 1 vial / carton |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
This page is written for hospital pharmacists, critical-care and infectious-disease department buyers, and pharmacies that source injectable antibiotics. The product is prescribed and supervised by a physician, as described in the prescribing information.
The Zosyn label lists, as most common adverse reactions (incidence above 5%), diarrhea, constipation, nausea, headache and insomnia. Its warnings cover serious hypersensitivity, severe cutaneous reactions, Clostridioides difficile-associated diarrhea and hematologic effects. This list is not complete; the full prescribing information governs.
All use should follow the approved prescribing information and the instructions of the treating physician.
Please follow the storage instructions printed on the Tazira Lyo carton and leaflet, including reconstitution and use-by times. Keep out of reach of children.
Tazira Lyo is marketed by Abbott. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Tazira Lyo through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Tazira Lyo available in India?
A.K. Pharma supplies Tazira Lyo (piperacillin + tazobactam) Piperacillin 4 g + Tazobactam 500 mg (4.5 g) injection to hospitals and pharmacies in India. Contact us for current availability.
What does Tazira Lyo contain?
Piperacillin 4 g with tazobactam 500 mg (4.5 g), a lyophilised antibiotic powder for injection.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Tazira Lyo be stored?
Follow the carton and leaflet, including time limits after reconstitution.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
